Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2)
- 7 September 2009
- journal article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 28 (45), 3983-3996
- https://doi.org/10.1038/onc.2009.264
Abstract
An elevated proteasome activity contributes to tumorigenesis, particularly by providing cancer cells with antiapoptotic protection and efficient clearance from irregular proteins. Still, the underlying mechanisms are poorly known. In this study, we report that in colon cancer patients, higher proteasome activity was detected in tumoral tissue compared with surrounding normal tissue, and also that increased levels of proteasomal subunit proteins, such as S5a/PSMD4 and α-5/PSMA5, could be detected. Colon tumors showed higher nuclear levels of nuclear factor E2-related factor 2 (Nrf2), a transcription factor supposed to be involved in the control of proteasomal subunit protein expression. The induction or overexpression of Nrf2 led to stronger S5a and α-5 expression in the human colon cancer cell lines, Colo320 and Lovo, as well as in NCM460 colonocytes along with higher proteasome activity. The small interfering RNA (siRNA)-mediated Nrf2 knockdown decreased S5a and α-5 expression and reduced proteasome activity. Additionally, Nrf2-dependent S5a and α-5 expression conferred protection from tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis, an effect preceded by an increased nuclear factor (NF)-κB activation and higher expression of antiapoptotic NF-κB target genes. These findings point to an important role of Nrf2 in the gain of proteasome activity, thereby contributing to colorectal carcinogenesis. Nrf2 may therefore serve as a potential target in anticancer therapy.Keywords
This publication has 68 references indexed in Scilit:
- Neutralization of complement regulatory proteins CD55 and CD59 augments therapeutic effect of herceptin against lung carcinoma cellsOncology Reports, 2009
- Immediate early gene-X1 interferes with 26 S proteasome activity by attenuating expression of the 19 S proteasomal components S5a/Rpn10 and S1/Rpn2Biochemical Journal, 2007
- Increased Proteasome Activity, Ubiquitin-Conjugating Enzymes, and eEF1A Translation Factor Detected in Breast Cancer TissueCancer Research, 2005
- Gene expression profiling of NRF2-mediated protection against oxidative injuryFree Radical Biology & Medicine, 2005
- The development of proteasome inhibitors as anticancer drugsCancer Cell, 2004
- The early response gene IEX-1 attenuates NF-κB activation in 293 cells, a possible counter-regulatory process leading to enhanced cell deathOncogene, 2003
- Emerging Roles of Ubiquitin in Transcription RegulationScience, 2002
- The proteasome: a novel target for cancer chemotherapyLeukemia, 2002
- The Proteasome: Paradigm of a Self-Compartmentalizing ProteaseCell, 1998
- STRUCTURE AND FUNCTIONS OF THE 20S AND 26S PROTEASOMESAnnual Review of Biochemistry, 1996